Advancement on breast cancer drug

Researchers suggest that a drug that halves a woman's risk of breast cancer continues to work long even after they stop taking it.

As per the researchers at Queen Mary University, London, only a tenth of eligible women was receiving it despite being already available on the NHS.

The growth of many breast cancers is fueled by the production of the hormone oestrogen. Anastrozole blocks its production. However, Anastrozole....